Insights That Move You Forward

Helping you make smarter decisions, avoid costly missteps, & bring safe, effective products to market with confidence

MedTech Regulatory Risk: Navigating the FDA During a Government Shutdown
Regulatory Strategy, FDA Insights, Risk Mitigation, Industry Commentary, Podcast Features Crystal Norwood Regulatory Strategy, FDA Insights, Risk Mitigation, Industry Commentary, Podcast Features Crystal Norwood

MedTech Regulatory Risk: Navigating the FDA During a Government Shutdown

When the U.S. government shuts down, FDA operations slow—and medical device companies can face costly delays. In this Global Medical Device Podcast Q&A, NMCG President and former FDA Scientific Reviewer Michael Nilo explains what continues, what stops, and how MedTech leaders can strategically navigate the disruption.

Read More
How a Government Shutdown Affects FDA Medical Device Regulation
Regulatory Strategy, FDA Submissions, Medical Device Submissions, Policy & Compliance Michael Nilo Regulatory Strategy, FDA Submissions, Medical Device Submissions, Policy & Compliance Michael Nilo

How a Government Shutdown Affects FDA Medical Device Regulation

Government shutdowns don’t completely stop the FDA—but they do create unpredictability. While essential functions like recalls and safety monitoring continue, new submissions, inspections, and policy development often stall. Learn what history tells us about shutdown impacts and how device makers can prepare.

Read More